Dr Linda Siminerio, a leading expert in diabetes education and healthcare delivery, shares insights from her distinguished career. Inspired by her father’s type 1 diabetes diagnosis, she has dedicated her work to improving patient education and care models. She emphasizes the importance of a team-based approach and staying ahead of technological advancements. With AI and machine learning already influencing diabetes management, she urges healthcare providers to adapt and engage with these innovations. Through her contributions, Dr Siminerio continues to shape the future of diabetes care, ensuring that patients receive the education and support they need.

Dr Svenja Nölting shares how her international experiences and dedicated mentors shaped her career in neuroendocrine oncology, discusses the profound impact of hormones on the body, and highlights the future of precision medicine in tailoring treatments for endocrine disorders.

Eneboparatide is an investigational parathyroid hormone receptor 1 (PTH1R) agonist, designed to bind with high affinity to a specific conformation of PTH1R, which is expressed in the kidneys and bone. The goal of treatment is to restore function by producing sustained and stable levels of calcium in the blood and by restoring calcium reabsorption by the kidney.2,3 Eneboparatide has been developed to have a short half-life in order to preserve bone health.

Watch four leading experts discuss how AI is transforming the clinical management of paediatric endocrine disorders including growth hormone disorders.

New research, published in the Nature journal, Communications Medicine has identified rare genetic variants that may contribute to the increased prevalence of type 2 diabetes (T2D) in multiple generations of Asian Indian families.1 The findings could provide new insights into ...

"From Adolescence to Menopause: Modern Management of Endometriosis and Uterine Diseases" will be the central theme of the 11th Annual SEUD Congress, taking place April 24–26, 2025, in Prague, Czech Republic. This premier event will unite global experts in gynecology, endometriosis, and uterine disorders to explore the latest advancements in research, diagnosis, and treatment. With an innovative scientific program, engaging discussions, and interactive sessions, SEUD 2025 promises to be an essential gathering for professionals committed to women’s health.

As we observe Rare Liver Disease Month this February, touchENDOCRINOLOGY is proud to join Global Liver Institute (GLI) in championing awareness for rare liver diseases. Although primarily managed within hepatology, many rare liver diseases have strong links to endocrinology due ...

This year the fields of paediatric and adult endocrinology are coming together in a new collaboration. The European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) will co-host their first-ever joint Congress on 10–13 May 2025 at the Bella Centre in Copenhagen, Denmark. This unique event, with the theme ‘Connecting Endocrinology Across the Life Course’, will unite specialists from across the world to foster collaboration, share knowledge and advance clinical care.

New research presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), The Liver Meeting, reveals a connection between low levels of anti-Müllerian hormone (AMH) and the risk of metabolic-associated steatotic liver disease (...